Exercise for COVID-19 Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if exercise can aid recovery from COVID-19 by reducing lingering symptoms like fatigue. Researchers are testing a program where participants either engage in Aerobic Exercise Training (a structured exercise program) and attend education classes or attend only education classes for the first 10 weeks, then switch roles. Adults aged 18-80 who had COVID-19 and still experience symptoms like tiredness may qualify. Participants will undergo various health tests and exercise on a treadmill while being monitored. Additionally, they will wear an activity monitor and maintain contact for a year after the trial.
As a Phase 1, Phase 2 trial, this research focuses on understanding how the treatment works in people and measuring its effectiveness in an initial, smaller group.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you must stop taking your current medications. However, if you are on medications that influence exercise performance, like beta blockers or antiretroviral therapy, you may be excluded from participating.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes people on medications that would influence exercise performance, like beta blockers or antiretroviral therapy. It's best to discuss your specific medications with the trial team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that aerobic exercise can be safe and beneficial for people recovering from COVID-19. One study found that a 5-week program of aerobic exercise, combined with breathing exercises, improved heart and lung health in participants, indicating the exercise was well-tolerated.
Another study discovered that individuals with post-COVID-19 symptoms, such as fatigue and shortness of breath, experienced improvement after supervised exercise sessions. This suggests that although some may initially find exercise challenging, it can have a positive effect without causing serious side effects.
These findings indicate that aerobic exercise is generally safe for those recovering from COVID-19. However, since experiences vary, individuals should pay attention to their bodies and consult a healthcare provider.12345Why are researchers excited about this trial?
Researchers are excited about using aerobic exercise training for COVID-19 recovery because it offers a non-pharmacological approach to enhance recovery. Unlike standard treatments that often involve medications targeting symptoms or the virus itself, aerobic exercise aims to improve physical health and respiratory function through increased cardiovascular activity. This approach leverages the body's natural ability to heal and strengthen itself, potentially leading to improved long-term outcomes without the side effects associated with drug therapies. Additionally, combining exercise with education empowers patients with knowledge about managing their recovery, which could lead to more sustainable health improvements.
What evidence suggests that this trial's treatments could be effective for COVID-19 recovery?
Research has shown that exercise programs can significantly aid people recovering from COVID-19. In this trial, participants will join different treatment arms. One group will receive Aerobic Exercise Training and Education, while another will start with Education only before adding exercise. Studies have found that these programs improve both physical and mental health. For instance, patients have performed better on the 6-minute walk test, which measures endurance by assessing how far one can walk in six minutes. Exercise also strengthens the heart and lungs, making it easier for recovering patients to breathe and move. Overall, these exercises enhance quality of life by reducing shortness of breath and increasing the ability to perform everyday activities.56789
Who Is on the Research Team?
Leighton Chan, M.D.
Principal Investigator
National Institutes of Health Clinical Center (CC)
Are You a Good Fit for This Trial?
Adults aged 18-80 who had COVID-19 and are still experiencing symptoms like fatigue or physical limitations can join. They must understand English or Spanish, agree to the study's procedures, and have confirmed past infection with lab tests. People with severe psychiatric issues, certain medical conditions, extreme obesity (BMI > 40), or on conflicting medications cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo medical history, physical exam, and various tests including heart and lung function, blood vessel assessment, and muscle ultrasound
Treatment
Participants engage in aerobic exercise training and education for 10 weeks, with assessments of physical function and health-related quality of life
Crossover Treatment
Participants in the control group crossover to perform aerobic exercise training for 10 weeks
Follow-up
Participants are monitored for free-living physical activity, sleep quality, and health-related quality of life every 3 months for 1 year
What Are the Treatments Tested in This Trial?
Interventions
- Aerobic Exercise Training
- Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Institutes of Health Clinical Center (CC)
Lead Sponsor